SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
MacroGenics, Inc. and Eli Lilly and Company Announce Pivotal Clinical Trial of Diabetes Drug Teplizumab Did Not Meet Primary Efficacy Endpoint
Your Message